• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD PROBETEC¿ CHLAMYDIA TRACHOMATIS (CT) QX AMPLIFIED DNA ASSAY REAGENT PACK; DNA PROBE, NUCLEIC ACID AMPLIFICATION, CHLAMYDIA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD PROBETEC¿ CHLAMYDIA TRACHOMATIS (CT) QX AMPLIFIED DNA ASSAY REAGENT PACK; DNA PROBE, NUCLEIC ACID AMPLIFICATION, CHLAMYDIA Back to Search Results
Catalog Number 441126
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/11/2023
Event Type  malfunction  
Event Description
1 of 3: it was reported that while customer was performing cross-platform testing with xtr and max using bd probetec¿ chlamydia trachomatis (ct) qx amplified dna assay reagent pack, patient sample was discrepant on xtr only.The results have not been reported.
 
Manufacturer Narrative
H3.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.D4.Medical device expiration date: unknown.H4.Device manufacture date: unknown.
 
Manufacturer Narrative
H.6.Investigation summary: bd integrated diagnostic system initiated an investigation into discrepant results on the bd viper xtr system (catalog # 441126, batch # unknown).Bd investigation required complaint trending review.There are no current trends associated with discrepant results on the bd viper xtr system.Bd was unable to perform batch history record reviews and functional analysis due to the lack in batch information provided.Bd was unable to confirm the customers report.
 
Event Description
1 of 3: it was reported that while customer was performing cross-platform testing with xtr and max using bd probetec¿ chlamydia trachomatis (ct) qx amplified dna assay reagent pack, patient sample was discrepant on xtr only.The results have not been reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD PROBETEC¿ CHLAMYDIA TRACHOMATIS (CT) QX AMPLIFIED DNA ASSAY REAGENT PACK
Type of Device
DNA PROBE, NUCLEIC ACID AMPLIFICATION, CHLAMYDIA
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
jo doyka
7 loveton circle
sparks, MD 21152
4103164000
MDR Report Key18066890
MDR Text Key327306289
Report Number1119779-2023-01202
Device Sequence Number1
Product Code MKZ
UDI-Device Identifier00382904411268
UDI-Public(01)00382904411268
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K081824
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/03/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number441126
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/21/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-